A Self-assembly Carrier-Free Nanovaccine based on Fluorinated CpG and Neoantigen Peptides for Hepatocellular Carcinoma Immunotherapy

Neoantigen peptides evade central thymic tolerance due to their absence in normal tissues, making neoantigen vaccines a leading strategy for personalized cancer immunotherapy. Although nanoparticle-based delivery systems are widely used to enhance neoantigen immunogenicity, traditional nanovaccines...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Xiuyun Lin, Hui Li, Jie Liu, Guangfeng Wu, Liuqing Yao, Zhouwei Zhan, Xiufang Yang, Xiu Yang, Shuxian Cai, Na Yao, Fengfang Chen, Wenqiang Yan, Peng Lyu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2026-12-01
Rangatū:	International Journal of Pharmaceutics: X
Ngā marau:	Hepatocellular carcinoma Neoantigen nanovaccine Carrier-free nanovaccine；immunotherapy
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S259015672600126X
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!